Release of Membrane-Bound Vesicles and Inhibition of Tumor Cell Adhesion by the Peptide Neopetrosiamide A

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Austin, Pamela ^a   Heller, Markus ^a   Williams, David E ^a   McIntosh, Lawrence P ^a   Vogl, A Wayne ^a   Foster, Leonard J ^a   Andersen, Raymond J ^a   Roberge, Michel ^a   Roskelley, Calvin D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; ANTINEOPLASTIC AGENT; BETA1 INTEGRIN; COFILIN; MOESIN; MYOSIN; MYOSIN IC; NEOPETROSIAMIDE A; PAXILLIN; SCAFFOLD PROTEIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; VINCULIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL ADHESION; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; FOCAL ADHESION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MEMBRANE VESICLE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; PROTEOMICS; STRUCTURE ANALYSIS; TEMPERATURE SENSITIVITY; TUMOR CELL;

ANTIGENS, CD29; CELL ADHESION; CELL LINE, TUMOR; CELL MEMBRANE; CELL SURFACE EXTENSIONS; CYTOPLASMIC VESICLES; FOCAL ADHESIONS; HUMANS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASMS; PEPTIDES, CYCLIC; PROTEIN SUBUNITS; TEMPERATURE;

EID: 77956271187     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010836     Document Type: Article

References (52)

1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70.
2. Ruoslahti E, Pierschbacher MD (1986) Arg-Gly-Asp: a versatile cell recognition signal. Cell 44: 517-518.
3. Dunehoo AL, Anderson M, Majumdar S, Kobayashi N, Berkland C, et al. (2006) Cell adhesion molecules for targeted drug delivery. J Pharm Sci 95: 1856-1872.
4. Cai W, Chen X (2006) Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism. Anticancer Agents Med Chem 6: 407-428.
5. Hehlgans S, Haase M, Cordes N (2007) Signalling via integrins: implications for cell survival and anticancer strategies. Biochim Biophys Acta 1775: 163-180.
6. Martin MD, Matrisian LM (2007) The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev 26: 717-724.
7. Coussens LM, Fingleton B, Matrisian LM (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392.
8. Wyckoff JB, Pinner SE, Gschmeissner S, Condeelis JS, Sahai E (2006) ROCK-and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol 16: 1515-1523.
9. Elvin P, Garner AP (2005) Tumour invasion and metastasis: challenges facing drug discovery. Curr Opin Pharmacol 5: 374-381.
10. Roskelley CD, Williams DE, McHardy LM, Leong KG, Troussard A, et al. (2001) Inhibition of tumor cell invasion and angiogenesis by motuporamines. Cancer Res 61: 6788-6794.
11. McHardy LM, Sinotte R, Troussard A, Sheldon C, Church J, et al. (2004) The tumor invasion inhibitor dihydromotuporamine C activates RHO, remodels stress fibers and focal adhesions, and stimulates sodium-proton exchange. Cancer Res 64: 1468-1474.
12. Warabi K, McHardy LM, Matainaho L, Van Soest R, Roskelley CD, et al. (2004) Strongylophorine-26, a new meroditerpenoid isolated from the marine sponge Petrosia (Strongylophora) corticata that exhibits anti-invasion activity. J Nat Prod 67: 1387-1389.
13. McHardy LM, Warabi K, Andersen RJ, Roskelley CD, Roberge M (2005) Strongylophorine-26, a Rho-dependent inhibitor of tumor cell invasion that reduces actin stress fibers and induces nonpolarized lamellipodial extensions. Mol Cancer Ther 4: 772-778.
14. Diaz-Marrero AR, Austin P, Van Soest R, Matainaho T, Roskelley CD, et al. (2006) Avinosol, a meroterpenoid-nucleoside conjugate with antiinvasion activity isolated from the marine sponge Dysidea sp. Org Lett 8: 3749-3752.
15. Williams DE, Austin P, Diaz-Marrero AR, Soest RV, Matainaho T, et al. (2005) Neopetrosiamides, peptides from the marine sponge Neopetrosia sp. that inhibit amoeboid invasion by human tumor cells. Org Lett 7: 4173-4176.
16. Boerner JL, Gibson MA, Fox EM, Posner ED, Parsons SJ, et al. (2005) Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells. Mol Endocrinol 19: 2660-2670.
17. Liu H, Boudreau MA, Zheng J, Whittal RM, Austin P, et al. Chemical synthesis and biological activity of the neopetrosiamides and their analogues: revision of disulfide bond connectivity. J Am Chem Soc 132: 1486-1487.
18. Keezer SM, Ivie SE, Krutzsch HC, Tandle A, Libutti SK, et al. (2003) Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin. Cancer Res 63: 6405-6412.
19. Bonilha VL, Bhattacharya SK, West KA, Sun J, Crabb JW, et al. (2004) Proteomic characterization of isolated retinal pigment epithelium microvilli. Mol Cell Proteomics 3: 1119-1127.
20. Paradela A, Bravo SB, Henriquez M, Riquelme G, Gavilanes F, et al. (2005) Proteomic analysis of apical microvillous membranes of syncytiotrophoblast cells reveals a high degree of similarity with lipid rafts. J Proteome Res 4: 2435-2441.
21. Jovic M, Naslavsky N, Rapaport D, Horowitz M, Caplan S (2007) EHD1 regulates beta1 integrin endosomal transport: effects on focal adhesions, cell spreading and migration. J Cell Sci 120: 802-814.
22. Kuo HJ, Tran NT, Clary SA, Morris NP, Glanville RW (2001) Characterization of EHD4, an EH domain-containing protein expressed in the extracellular matrix. J Biol Chem 276: 43103-43110.
23. Sharma M, Naslavsky N, Caplan S (2008) A role for EHD4 in the regulation of early endosomal transport. Traffic 9: 995-1018.
24. Xu D, Hemler ME (2005) Metabolic activation-related CD147-CD98 complex. Mol Cell Proteomics 4: 1061-1071.
25. Kolesnikova TV, Mannion BA, Berditchevski F, Hemler ME (2001) Beta1 integrins show specific association with CD98 protein in low density membranes. BMC Biochem 2: 10.
26. Zent R, Fenczik CA, Calderwood DA, Liu S, Dellos M, et al. (2000) Class- and splice variant-specific association of CD98 with integrin beta cytoplasmic domains. J Biol Chem 275: 5059-5064.
27. Wang L, Zhou X, Zhou T, Ma D, Chen S, et al. (2008) Ecto-59-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. J Cancer Res Clin Oncol 134: 365-372.
28. Bowen MA, Patel DD, Li X, Modrell B, Malacko AR, et al. (1995) Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 181: 2213-2220.
29. Park SK, Lee HS, Lee ST (1996) Characterization of the human full-length PTK7 cDNA encoding a receptor protein tyrosine kinase-like molecule closely related to chick KLG. J Biochem 119: 235-239.
30. Maciver SK, Hussey PJ (2002) The ADF/cofilin family: actin-remodeling proteins. Genome Biol 3: reviews3007.
31. Tsukita S, Yonemura S (1999) Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins. J Biol Chem 274: 34507-34510.
32. Sokac AM, Schietroma C, Gundersen CB, Bement WM (2006) Myosin-1c couples assembling actin to membranes to drive compensatory endocytosis. Dev Cell 11: 629-640.
33. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25.
34. Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, et al. (2008) Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol.
35. Frisch SM, Screaton RA (2001) Anoikis mechanisms. Curr Opin Cell Biol 13: 555-562.
36. Westhoff MA, Fulda S (2009) Adhesion-mediated apoptosis resistance in cancer. Drug Resist Updat 12: 127-136.
37. Lakkaraju A, Rodriguez-Boulan E (2008) Itinerant exosomes: emerging roles in cell and tissue polarity. Trends Cell Biol 18: 199-209.
38. Dolo V, Ginestra A, Ghersi G, Nagase H, Vittorelli ML (1994) Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. J Submicrosc Cytol Pathol 26: 173-180.
39. Pluskota E, Woody NM, Szpak D, Ballantyne CM, Soloviev DA, et al. (2008) Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles. Blood 112: 2327-2335.
40. Hirokawa N, Tanaka Y, Okada Y, Takeda S (2006) Nodal flow and the generation of left-right asymmetry. Cell 125: 33-45.
41. Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles: artefacts no more. Trends Cell Biol 19: 43-51.
42. Eble JA, Haier J (2006) Integrins in cancer treatment. Curr Cancer Drug Targets 6: 89-105.
43. Wouters MA, Rigoutsos I, Chu CK, Feng LL, Sparrow DB, et al. (2005) Evolution of distinct EGF domains with specific functions. Protein Sci 14: 1091-1103.
44. Lirazan MB, Hooper D, Corpuz GP, Ramilo CA, Bandyopadhyay P, et al. (2000) The spasmodic peptide defines a new conotoxin superfamily. Biochemistry 39: 1583-1588.
45. Buczek O, Bulaj G, Olivera BM (2005) Conotoxins and the posttranslational modification of secreted gene products. Cell Mol Life Sci 62: 3067-3079.
46. Han KH, Hwang KJ, Kim SM, Kim SK, Gray WR, et al. (1997) NMR structure determination of a novel conotoxin, [Pro 7,13] alpha A-conotoxin PIVA. Biochemistry 36: 1669-1677.
47. Rogers LD, Foster LJ (2007) The dynamic phagosomal proteome and the contribution of the endoplasmic reticulum. Proc Natl Acad Sci U S A 104: 18520-18525.
48. Le PU, Nabi IR (2003) Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum. J Cell Sci 116: 1059-1071.
49. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, et al. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6: 277-293.
50. Linge JP, Habeck M, Rieping W, Nilges M (2003) ARIA: automated NOE assignment and NMR structure calculation. Bioinformatics 19: 315-316.
51. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, et al. (1998) Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54: 905-921.
52. Hutchinson EG, Thornton JM (1996) PROMOTIF-a program to identify and analyze structural motifs in proteins. Protein Sci 5: 212-220.